Nephrology Times
Advertisement
A study examined bone health among a subset of kidney transplant patients from the PROTECT trial of pegloticase for gout.
Could a combined nutritional supplementation and exercise training program improve frailty and health outcomes with CKD?
Researchers examined the association between gout and odds of being wait-listed for a kidney transplant among patients on HD.
Health professionals should promote the benefits of fruits and vegetables, especially to patients receiving dialysis.
Is metformin use ever appropriate for patients with advanced kidney disease and type 2 diabetes?
Oral iptacopan (Fabhalta) has become the first FDA-approved treatment for proteinuria in adults with C3 glomerulopathy.
A study compared stroke and dementia risk between race-free and previous eGFR equations.
Freely Filtered returns with another episode for NephMadness, this time, covering the hemodialysis region.
The Freely Filtered Filtrate discusses the top nephrology stories of 2024, including FLOW, cyberattacks, and IgAN trials.
Researchers estimated tuberculosis incidence and described the disease among the US population with kidney failure.
A study examined whether kidney function decline accelerated after COVID-19 versus other respiratory infections.
What were the effects of moving calcimimetics from the TDAPA to an increased bundled payment?
Babak Orandi spoke with us about a study showing that GLP-1 drugs have benefits for kidney transplant recipients with T2D.
Is coprescription of gabapentinoids with other psychoactive medications associated with altered mental status and falls?
A study assessed the role of and patterns of multimorbidity and their association with kidney function decline.
The American Kidney Fund's Living Donor Report Card found that many US states lack protections for living kidney donors.
A new innovation center in Boston will serve as Roche's cardiovascular, renal, and metabolism research and development hub.
Furosemide (Furoscix) has been approved by the FDA for the treatment of edema in patients with chronic kidney disease (CKD).
Do changes in UPCR during severe AKI episodes affect how serum creatinine levels change at the time of sample collection?
KDIGO has published its first guideline on the evaluation, management, and treatment of ADPKD.
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.